Loading people...
Martina de Majo is the Director of Research and Development at Synapticure, where she leads the development of induced pluripotent stem cell (iPSC)-derived in vitro models for neurodegenerative disorders. She began her academic training in Italy, earning both an undergraduate science degree in biotechnology and a master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza." Following her foundational studies in Rome, de Majo relocated to the United Kingdom to complete a doctorate in clinical neuroscience at King's College London. She subsequently advanced her expertise in regenerative medicine platforms through specialized postdoctoral training focused on iPSC-derived modeling at the University of California, San Francisco (UCSF). Today, her primary professional focus centers on bridging pharmaceutical development and clinical neuroscience to create advanced cellular models for studying and treating complex neurodegenerative diseases and related disorders.
Martina de Majo is Founder at Synapticure.
Martina de Majo co-founded Synapticure.